Identification of the activating cytotoxicity receptor NKG2D as a senescence marker in zero-hour kidney biopsies is indicative for clinical outcome

MLA

Bettina Zelger, et al. “Identification of the Activating Cytotoxicity Receptor NKG2D as a Senescence Marker in Zero-Hour Kidney Biopsies Is Indicative for Clinical Outcome.” Kidney International, vol. 91, June 2017, pp. 1447–63. EBSCOhost, https://doi.org/10.1016/j.kint.2016.12.018.

APA

Bettina Zelger, Andreas Pascher, Stefan Schneeberger, H. G. Schwelberger, Robert Öllinger, Katja Kotsch, Johann Pratschke, Paul Viktor Ritschl, Hubert Hackl, Diana Stauch, Gerald Brandacher, Arne Sattler, Julia Günther, Matthias Biebl, Thomas Resch, & Susanne Ebner. (2017). Identification of the activating cytotoxicity receptor NKG2D as a senescence marker in zero-hour kidney biopsies is indicative for clinical outcome. Kidney International, 91, 1447–1463. https://doi.org/10.1016/j.kint.2016.12.018

Chicago

Bettina Zelger, Andreas Pascher, Stefan Schneeberger, H. G. Schwelberger, Robert Öllinger, Katja Kotsch, Johann Pratschke, et al. 2017. “Identification of the Activating Cytotoxicity Receptor NKG2D as a Senescence Marker in Zero-Hour Kidney Biopsies Is Indicative for Clinical Outcome.” Kidney International 91 (June): 1447–63. doi:10.1016/j.kint.2016.12.018.